BioSpace News Archive

Press Releases

Apogee Therapeutics Announces Positive Phase 2 Part A 52-Week Data of Zumilokibart (APG777), Demonstrating Maintenance and Deepening of Responses with Every 3- and 6-Month Dosing in Moderate-to-Severe Atopic Dermatitis

March 23, 2026
·
10 min read
Press Releases

Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic Atrophy

March 23, 2026
·
3 min read
Press Releases

Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

March 23, 2026
·
16 min read
Press Releases

Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates

March 23, 2026
·
12 min read
Press Releases

Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

March 23, 2026
·
8 min read
Press Releases

Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics

March 23, 2026
·
5 min read
Press Releases

Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company

March 23, 2026
·
6 min read
Press Releases

Kali Therapeutics Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Tri-Specific T-Cell Engager for Autoimmune Diseases

March 23, 2026
·
2 min read
Press Releases

Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)

March 23, 2026
·
8 min read
Press Releases

Tessera Therapeutics Receives Grant to Advance In Vivo Gene Writing Approaches Towards a Potential Human Immunodeficiency Virus (HIV) Cure

March 23, 2026
·
2 min read